These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7664914)

  • 1. Clinico-pathological correlation of glucagon-positive pancreatic endocrine tumours: a presentation of five cases.
    Wat MS; Lam KY; Lam KS
    Eur J Surg Oncol; 1995 Aug; 21(4):428-9. PubMed ID: 7664914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine regulates glucagon secretion from human glucagonoma cells.
    Funakoshi A; Yasunami Y; Ryu S; Shinozaki H; Jimi A; Ikeda S
    J Gastroenterol; 1994 Dec; 29(6):797-9. PubMed ID: 7874280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case with glucagonoma syndrome--endocrine and metabolic studies.
    Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
    Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron microscopic and immunoelectron microscopic demonstration of pancreatic polypeptide cells in glucagonoma: colocalization of pancreatic peptide and glucagon in single secretory granules.
    Ooi A; Katsuda S; Nakanishi I; Kameya T; Yamaguchi K; Kitamura H; Hayakawa Y
    Ultrastruct Pathol; 1989; 13(1):15-22. PubMed ID: 2537546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of glucagon-containing peptides in a human pancreatic glucagonoma and its liver metastasis.
    Alarcón C; Kervran A; Bataille D; Valverde I
    Horm Metab Res; 1991 Jun; 23(6):290-2. PubMed ID: 1916643
    [No Abstract]   [Full Text] [Related]  

  • 7. Amylin in pancreatic islets and pancreatic endocrine neoplasms.
    Tomita T
    Pathol Int; 2003 Sep; 53(9):591-5. PubMed ID: 14507315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic glucagonoma with and without syndrome. Immunocytochemical study of 5 tumour cases and review of the literature.
    Ruttman E; Klöppel G; Bommer G; Kiehn M; Heitz PU
    Virchows Arch A Pathol Anat Histol; 1980; 388(1):51-67. PubMed ID: 6258288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study.
    Eissele R; Göke R; Weichardt U; Fehmann HC; Arnold R; Göke B
    Cell Tissue Res; 1994 Jun; 276(3):571-9. PubMed ID: 8062345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A glucagon-secreting alpha-cell carcinoma of the pancreas].
    Matsumoto J; Noto N; Kikuchi Y; Kitazima S; Kaimori M; Sasaki G; Ohto T; Nakamura K
    Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):330-4. PubMed ID: 2987580
    [No Abstract]   [Full Text] [Related]  

  • 11. [An autopsy case of glucagonoma associated with production of several hormones].
    Fujise K; Matsuura T; Nakagawa J; Egawa K; Hihara M; Nakahara M; Kawase H; Kitahara T; Ohara K; Joh K
    Nihon Naika Gakkai Zasshi; 1988 Jun; 77(6):880-1. PubMed ID: 2906354
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
    Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA
    Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
    White A; Tan K; Gray C; Roberts I; Ratcliffe JG
    Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
    Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
    Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucagonoma syndrome: surgically curable diabetes.
    Higgins GA; Recant L; Fischman AB
    Am J Surg; 1979 Jan; 137(1):142-8. PubMed ID: 215044
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.
    Holst JJ
    Diabetologia; 1983 May; 24(5):359-65. PubMed ID: 6307793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein in pancreatic endocrine neoplasms.
    Tomita T
    Mod Pathol; 2000 Apr; 13(4):389-95. PubMed ID: 10786804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of glucagonoma conducted on the metastatic lymph nodes from a patient with recurrent metastatic glucagonoma: report of a case.
    Kawakita N; Nagahata Y; Yoshizumi K; Wada T; Yamamoto M; Saitoh Y; Urakawa T
    Surg Today; 1994; 24(10):918-22. PubMed ID: 7894192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FA1 immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression.
    Tornehave D; Jensen CH; Teisner B; Larsson LI
    Histochem Cell Biol; 1996 Dec; 106(6):535-42. PubMed ID: 8985741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.